Kunkel Lori Anne 4
4 · Oric Pharmaceuticals, Inc. · Filed Dec 9, 2025
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$7.90/sh+10,000$79,000→ 84,200 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-08−10,000→ 15,600 totalExercise: $7.90Exp: 2034-06-11→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.